Liquid stock solutions dissolved in pure DMSO remain stable at -80C in single-use aliquots for up to 6 months
(See Figure 2 for a timeline of key activities associated with the GLP-1 coverage demonstrations.) Medicare coverage of GLP-1s for obesity begins in July 2026 through the Medicare GLP-1 Bridge and will be extended through the end of 2027 CMS will provide Part D beneficiaries with coverage of select GLP-1s for obesity from July 1, 2026 to December 31, 2027 (originally December 31, 2026) through the Medicare GLP-1 Bridge, which is a short-term demonstration established using Section 402 demonstration authority
PlexusDx eliminates these obstacles by delivering prescription-strength compounded medications directly to your doorno insurance required, no prior authorization delays, no membership fees
The strongest medical weight loss plans also consider nutrition, resistance training, hydration, sleep, stress, lab markers, medication tolerance, body composition, side-effect management, and long-term maintenance